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TOOLS AND RESOURCES
Screening and purification of natural products from actinomycetes
that affect the cell shape of fission yeast
Richard A. Lewis1,2,*, Juanjuan Li1,*, Nicholas E. E. Allenby2, Jeffery Errington2, Jacqueline Hayles1,‡ and
Paul Nurse1
ABSTRACT
This study was designed to identify bioactive compounds that alter
the cellular shape of the fission yeast Schizosaccharomyces pombe
by affecting functions involved in the cell cycle or cell morphogenesis.
We used a multidrug-sensitive fission yeast strain, SAK950 to screen
a library of 657 actinomycete bacteria and identified 242 strains that
induced eight different major shape phenotypes in S. pombe. These
include the typical cell cycle-related phenotype of elongated cells,
and the cell morphology-related phenotype of rounded cells. As a
proof of principle, we purified four of these activities, one of which is a
novel compound and three that are previously known compounds,
leptomycin B, streptonigrin and cycloheximide. In this study, we have
also shown novel effects for two of these compounds, leptomycin B
and cycloheximide. The identification of these four compounds and
the explanation of the S. pombe phenotypes in terms of their known,
or predicted bioactivities, confirm the effectiveness of this approach.
KEY WORDS: Fission yeast, Actinomycetes, Natural product, Cell
shape, Polyene, Leptomycin B, Cycloheximide
INTRODUCTION
The fission yeast Schizosaccharomyces pombe is a rod-shaped
unicellular eukaryote that grows by apical extension and divides by
medial fission and septation (Mitchison and Nurse, 1985). It has a
typical eukaryotic cell cycle and this, together with the highly
polarised growth pattern, makes it an excellent organism for
studying the mechanisms involved in cell reproduction and the
generation of cell form. Both the cell cycle and cell morphology are
frequently altered in cancer cells, and mutations that alter these
processes play a key role in the development of disease, for example
in altering growth control (Beauchamp and Platanias, 2013;
Johnson and Halder, 2014), promoting delamination from a
epithelial layer (Dekanty et al., 2015) and penetration of
surrounding tissues during metastasis (Broustas and Lieberman,
2014). Indeed, morphological features are frequently used in cancer
diagnosis. Around 142 genes have been identified in S. pombe as
being conserved in humans and involved in cancer (Wood et al.,
2002; http://www.pombase.org). It follows that compounds capable
of perturbing the cell cycle or cell morphology in S. pombe may
have similar effects in human cells and thus find utility in
understanding the cell cycle, cell morphology and cancer, and in
the development of anticancer treatments.
Random or site-specific mutagenesis, followed by screening for
cells exhibiting aberrant shapes has allowed identification of many
genes involved in the cell cycle and cell morphology in fission
yeast (Nurse et al., 1976; Nurse and Thuriaux, 1980; Nasmyth and
Nurse, 1981; Verde et al., 1995; Snaith and Sawin, 2003). These
approaches led to the identification of the conserved Cdc2 (CDK1 in
mammals) kinase, its regulatory subunit, the cyclin B Cdc13, and its
regulators, the Wee1 tyrosine kinase and the Cdc25 tyrosine
phosphatase (Nurse, 1990). Dephosphorylation of Cdc2 at Y15
allows a rise in Cdc2 kinase activity and entry into mitosis; thus, its
timing is critical for regulating entry into mitosis (Simanis and
Nurse, 1986; Russell and Nurse, 1986, 1987; Gould and Nurse,
1989). Other approaches have utilised near genome-wide deletion
collections of essential and/or non-essential genes to identify new
genes involved in these processes (Deshpande et al., 2009; Kelly
and Nurse, 2011; Navarro and Nurse, 2012; Hayles et al., 2013;
Graml et al., 2014).
As an extension of these approaches, we have designed a screen
for natural compounds having an effect on the cellular shape of S.
pombe to identify chemical entities affecting the functions involved
in these processes. The development and use of such compounds as
research tools to dissect the molecular mechanisms regulating the
cell cycle and cell morphology will increase the range of available
experimental methodologies. We have previously screened libraries
of synthetic compounds produced by combinatorial chemistry
(Takemoto et al., 2016; Kawashima et al., 2016), and decided to
extend these studies by screening a library of bacterial isolates
comprised of actinomycete strains. Actinomycetes arewell known for
synthesising natural products, for example, bleomycin (Umenzawa
et al., 1966) and adriamycin (Arcamone et al., 1969), with anti-
eukaryotic cell activities. The rationale behind this approach was that
as the mechanisms that determine cell morphology and cell cycle in
prokaryotic and eukaryotic organisms are different, and as soil-
dwelling bacteria may be competing in the same ecological niche as
fungi, these eukaryotic-specific processes could be targets for
bacterially synthesised secondary metabolites (Ho and Nodwell,
2016). Thus, evolution would have naturally selected for prokaryotes
able to produce antifungal agents, and thus may provide a richer
source of ‘hits’ than would be obtained from a library of randomly
synthesised molecules.
Phenotypic screens to identify novel bioactive natural products
have been used previously; for example, fumagillin was isolated
from fungal metabolites, and this compound induced endothelial
cell rounding and inhibited angiogenesis (Ingber et al., 1990).Received 4 July 2016; Accepted 21 July 2017
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Additionally, cell cycle-blocking agents from actinomycetes and
fungi have been identified using S. cerevisiae as a screening tool
(Tsuchiya et al., 2010). A number of screens have also been carried
out in S. pombe using the viable haploid gene deletion mutant
library to examine sensitivity of these mutants to known compounds
(Deshpande et al., 2009; Gatti et al., 2011), and a study using wild-
type S. pombe has looked at the effects of known natural products on
cell shape by using FACS (Heisler et al., 2014). The objective of the
work described here is to identify bioactive natural products through
their effects on S. pombe cell shape by visual microscopic screening.
We have assayed 657 bacterial strains for their effects on the
multidrug-sensitive fission yeast strain SAK950 (Table S1), and
report further analysis of the induced phenotype and purification of
the active compound from four of these strains as a proof of
principle for this experimental approach.
RESULTS
Cell shape screening assay
To examine the effects of bioactivities, we used a S. pombe strain
(SAK950) with increased sensitivity to different compounds due to
deletion of seven protein-encoding genes affecting drug efflux (Aoi
et al., 2014) (Table S2).
A total of 657 actinomycete bacterial strains (http://demuris.co.
uk) were tested for the production of bioactivities affecting the
cellular shape of fission yeast (see Materials and Methods for
details). We found 420 bacterial strains that led to the formation of a
halo around the bacterial plug, indicating the presence of inhibitory
bioactive natural products produced by the bacterial strain. For the
remaining strains, 237 did not form a halo, and the S. pombe strains
in the vicinity of the plug showed a wild-type phenotype.
Microscopic examination of S. pombe cells showed that of the
420 actinomycete strains that produced a halo, 178 killed fission
yeast without showing an obvious shape phenotype (described as
‘dead’ in Table S1). The remaining 242 strains produced activities
that induced a range of altered S. pombe cell shape phenotypes. We
classified these phenotypes into eight broad groups (Fig. 1,
Tables S3 and S4), related to the phenotypes observed in the
deletion mutant collection screen (Hayles et al., 2013). However,
the range of phenotypes exhibited did not completely overlap; for
example, analysis of the gene deletion collection did not identify
the swollen cell tip phenotype shown in Fig. 1C, suggesting that
bioactive compounds may induce a different range of phenotypes
compared with the gene deletions. This may be, for example,
because they can interact with several different target molecules/
binding sites within the cell, selectively inhibit particular activities
of multifunctional target molecule, or can modify, rather than
inactivate, a target molecule. We found that several strains induced
mixed phenotypes, for example, both ‘small’ and ‘rounded’, or both
‘asymmetric septum’ and ‘misshapen’; however, for the purposes of
classification, each of the bacterial strains was allocated to a single
phenotypic group based on its predominant phenotypic effect.
From the 242 strains with activities, we selected 149 strains,
which included representatives of all phenotypes classes (Tables S1
and S3), for further investigation due to the high penetrance or
Fig. 1. Examples of S. pombe cells from plug assays that exhibit the different classes of cell shape defects. Examples of (A) misshapen, (B) vacuolated,
(C) swollen cell tip, (D) lysis, (E) control SAK950, (F) small, (G) rounded, (H) multiseptated, (I) elongated, (J) asymmetric septum cell shape defects. Black
arrows in J indicate asymmetrically placed septa or an asymmetrically dividing cell. All cells within the halo, produced by the secreted bioactivity, were visually
screened, and representative images from one screen are shown. Scale bars: 10 µm.
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interest of the induced phenotypes. From this subset of strains, we
selected activities produced from B21P2 (asymmetric septum),
T342 (elongated), 5307(1B) (swollen cell tip) and IS1 (rounded)
actinomycete strains for immediate further analysis to establish
whether our approach was useful.
Characterization of an S. pombe asymmetry phenotype
induced by B21P2
The asymmetric septation phenotype induced by B21P2 (Fig. 1J)
was selected because this phenotype may be caused by a defect
in spatial organisation within the cell. During interphase,
microtubules are required for positioning of the nucleus in the
middle of the cell, and the position of the septum at cytokinesis is
normally dependent on the position of the nucleus (Chang and
Nurse, 1996; Paoletti and Chang, 2000; Daga et al., 2006). It is
therefore possible that this asymmetric septum phenotype induced
by B21P2 is associated with other asymmetries and may be the
result of a defective microtubule cytoskeleton and nuclear
positioning.
We treated PN5352 cells (Table S2) growing in YE4S liquid
medium with semi-purified extracts from B21P2 to examine the
microtubule cytoskeleton and nuclear position. A range of
phenotypes, including reduction or absence of interphase
microtubules, and asymmetric positioning of the nuclei and
septum (Fig. 2, see legend for details; Movies 1 and 2) was
observed. Cells also had a range of spindle defects, with one of the
predominant phenotypes observed being a nuclear microtubule
bundle or extended spindle (Fig. 2; Movie 2). It is possible that this
microtubule bundle/spindle may be related to the intranuclear
bundle observed when Ned1 is overproduced (Tange et al., 2002).
Formation of both the mitotic spindle and interphase microtubules is
dependent on the import and export of tubulin and factors required
for polymerization of microtubules (Sato and Toda, 2010). This
may be inhibited in the presence of B21P2 and lead to microtubule
cytoskeletal defects. In addition to microtubule defects, we also
observed asymmetric division of the nuclear membrane in the
presence of an abnormal mitotic spindle. It has previously been
observed that the nuclear membrane can undergo fission in the
absence of a mitotic spindle (Castagnetti et al., 2010). Our results
suggest that in the presence of B21P2 there may be a defect in
spindle attachment to the nuclear membrane, which allows
membrane fission to occur independently of spindle elongation
(Movie 2, lower right cell). B21P2 may also directly affect the
nuclear membrane and lead to differently sized nuclei (Fig. 2;
Movie 2, upper right cell). Some of these microtubule and nuclear
membrane defects have previously been described for cells treated
with leptomycin B (LMB), which inhibits nuclear export (Nishi
et al., 1994). We tested the effect of LMB on PN5352 cells, and
found that the phenotype of SAK950 was almost identical to that
seen with B21P2 (Fig. 2), suggesting the bioactive compound
produced by this strain might be LMB.
Purification and identification of the bioactive compound
from B21P2
To identify the natural product produced by B21P2 that is
responsible for the asymmetric septum phenotype, we purified it
and compared it with LMB. We found that medium D (INA5) was
the most effective production medium for the bioactive compound
after 7 days growth. Using these conditions, agar plates were
harvested and the bioactive compound was extracted by reverse-
phase flash chromatography, followed by an ethyl acetate extraction,
normal-phase flash chromatography, size exclusion chromatography,
preparative high-performance liquid chromatography (HPLC) and
mass spectrometry, as described in the Materials and Methods.
The results of the purification indicated that there were
two differing forms of the bioactive compound, which gave two
discrete peaks in the HPLC elution at an λ=350 nm absorption
spectrum trace. Eluate corresponding to both peaks was subjected
to mass spectrometry, which revealed the presence of an ion at
m/z=549.320 [M+Na]+ eluting at 14.6 min and an ion at
m/z=563.331 [M+Na]+ eluting at 15.2 min (Fig. 3A,B shows the
spectra from the two B21P2-derived active compounds). Querying
of the ‘Dictionary of Natural Products’ (http://dnp.chemnetbase.
com/faces/chemical/ChemicalSearch.xhtml) suggested that the
most likely candidates were leptomycin A (LMA) and LMB
(Hamamoto et al., 1983a,b). To confirm the identification of the
purified B21P2 ion at m/z=563.331 [M+Na]+ as LMB, a sample of
commercial LMB (Sigma L2913-5UG) was subjected to HPLC,
where it eluted at 15.2 min, and mass spectrometry, where it gave
an ion at m/z=563.333 [M+Na]+ (Fig. 3C). Additionally, the
fragmentation pattern of the LMB-derived ion at m/z=563.331
Fig. 2. Phenotype of S. pombe cells in the presence of B21P2 or LMB.
A total of 100 cells of strain PN5352 were examined for the major phenotypes
of asymmetric nucleus (AN), extended spindle (ES) and asymmetric septum
(AS) in the presence of B21P2 or LMB. Examples of S. pombe cells illustrating
these defects are shown. (A,B) Cells in absence of drug (AN, n=0/100 cells;
ES, n=0/100 cells; AS, n=0/100 cells). (C,D) Cells+B21P2 (1:100 dilution; AN,
n=43/100 cells; ES, n=41/100 cells; AS, n=29/39 septated cells). (E,F)
Cells+LMB (50 ng/ml; AN, n=30/100 cells; ES, n= 45/100 cells; AS, n=18/34
septated cells). Examples of asymmetric nucleus (green arrows), extended
spindle (yellow arrows) and asymmetric septation (white arrows) are
highlighted. Many cells show multiple defects. PN5352 cells were incubated in
B21P2 or LMB for 2 h. Scale bars: 5 µm.
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[M+Na]+ (Fig. 3E) was identical to the fragmentation pattern of the
B21P2-derived ion at m/z=563.333 [M+Na]+ (Fig. 3D) confirming
that our initial identification of the B21P2 bioactive compound as
LMB was correct.
Elongated cell phenotype induced by T342
Next, we investigated activities causing an elongated cell
phenotype (Fig. 1I): this phenotype is characteristic of a block in
cell cycle progression while cells continue to grow (Bonatti et al.,
1972) and screening for this phenotype has been instrumental in
identifying many of the genes required for cell cycle progression
(Nurse et al., 1976; Nurse and Thuriaux, 1980; Nasmyth
and Nurse, 1981). One way in which the cell cycle could be
blocked is by activation of a checkpoint delaying entry into mitosis
in response to DNA damage or stalled replication forks (Enoch
et al., 1992). Inability to activate the DNA checkpoint in the
presence of DNA damage or stalled replication forks allows cells
to enter mitosis to give a cut phenotype (Kelly et al., 1993; Saka
and Yanagida, 1993). Cds1 is required to activate the intra-S
checkpoint when DNA replication is stalled and Chk1 is activated
in response to DNA damage. Rad3 is an upstream activator of both
pathways (al-Khodairy et al., 1994). Actinomycetes are known to
produce DNA-damaging compounds, for example, the anti-cancer
agents bleomycin (Umenzawa et al., 1966) and adriamycin
(Arcamone et al., 1969). We decided to focus on T342 as a
representative example of an elongation-inducing strain and to
investigate whether this phenotype was due to checkpoint
activation by the bioactive natural product compound or a block
in cell cycle progression in the absence of checkpoint activation.
T342-induced cell elongation is Chk1 dependent
When T342 extract was added to a Rad52–GFP-expressing strain
(Table S2), the number of Rad52 foci increased compared to that
found in cells in the absence of T342 suggesting that cell elongation
in the presence of T342 is due to checkpoint activation as a result of
either stalled DNA replication or DNA damage (Lisby et al., 2001)
(Fig. S1). To test these two possibilities, we added semi-purified
T342 extract to 972h- cells (T342 is active in both wild-type 972h-
and SAK950 cells to a similar level; see Fig. S2, compare Awith C),
and rad3Δ, chk1Δ and cds1Δ strains (Table S2). Wild-type 972h-
cells and cells lacking Cds1 elongated, suggesting that Cds1
(required for the intra-S checkpoint) is not required for checkpoint
activation in the presence of T342 (Fig. 4A,B,E,F). Cells lacking
Chk1 (required for the DNA damage checkpoint) or Rad3 (required
upstream of both Cds1 and Chk1) did not elongate but entered
mitosis prematurely to give a cut phenotype (Kelly et al., 1993; Saka
and Yanagida, 1993; Yanagida, 1998) (Fig. 4B,C,G,H). These
results demonstrate that the elongation phenotype was due to
activation of the Chk1-dependent DNA checkpoint and suggest that
T342 causes DNA damage.
Fig. 3. Electrospraymass spectrometry
data for LMA and LMB purified from
B21P2 and commercially available
LMB. (A) B21P2 LMA [M+Na]+.
(B) B21P2 LMB [M+Na]+. (C) Sigma LMB
[M+Na]+. (D) MS/MS of the B21P2-
derived LMB ion atm/z=563.331 shown in
B. (E) MS/MS of Sigma LMB ion at
m/z=563.333 shown in C.
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Purification and identification of the bioactive compound
from T342
Medium H (GYM) agar plates were inoculated with T342 and
grown for 7 days, after which the plates were harvested and the
bioactive compound was extracted in a multi-step procedure as
described above. This initially comprised a ‘freebasing’ process
followed by reverse-phase flash chromatography, preparative HPLC
and mass spectrometry. The purification process resulted in
identification of a bioactive compound, which eluted in the HPLC
gradient at 11.5 min and produced an ion at m/z=529.135 [M+Na]+
(Fig. 5A). Querying of the Dictionary of Natural Products
suggested that the most likely candidate was streptonigrin (SN),
which possesses a very similar mass to that reported here. To
confirm the identity of the purified T342 activity as SN, a sample of
commercially purified SN (Sigma) was subjected to HPLC, where it
eluted at 11.5 min, and mass spectrometry, where it gave an ion at
m/z=529.135 [M+Na]+ (Fig. 5C). The fragmentation pattern of the
ion at the m/z=529.1330 species [M+Na]+ generated by SN
(Fig. 5D) was identical to the fragmentation pattern of the ion at
m/z=529.1338 species [M+Na]+ from T342 (Fig. 5B) confirming
that our initial identification was correct.
Additionally, we tested commercially available SN in a S. pombe
filter paper assay to see whether this gave a similar phenotype to the
purified bioactive compound from T342. We found that the
phenotype using SN was indistinguishable from that seen with
T342 (Fig. S2, compare C with D). Our results suggest that SN leads
directly or indirectly to DNA damage, as previously reported (see
Discussion).
Swollen cell tip phenotype induced by 5307(1B)
The phenotype induced by 5307(1B) was initially observed during
the screen as a thickened region, mainly at one of the cell tips
(Fig. 1C). Using a purer, more concentrated, extract we showed that
the phenotype was due to accumulation of cell wall or septal
material (Calcofluor staining material) at one of the cell tips
(Fig. 6A,B) causing a swollen cell tip. At late time points, the cell tip
became dramatically swollen (data not shown).
We purified the natural product produced by 5307(1B) that was
responsible for this phenotype to conclusively identify the activity.
We found that mediumAwas the most effective production medium
for the bioactive compound after 7 days of growth. Using these
conditions, agar plates were harvested and the bioactive compound
was extracted by reverse-phase flash chromatography followed by
an ethyl acetate extraction, normal-phase flash chromatography,
preparative HPLC and mass spectrometry as described in the
Materials and Methods.
Despite not being detected during the HPLC using any of the
wavelengths used by the diode array detector (DAD) array, two
fractions eluting at between 10 and 10.5 min containing the active
compound were identified by filter disc bioassay. These were
subjected to mass spectrometry and both revealed the presence of an
ion at m/z=304.1525 [M+Na]+ (Fig. 7A). Querying of the
Dictionary of Natural Products for a mass of 281.163 revealed
cycloheximide to be a candidate, as this was given a result of 281.35.
To test this, a sample of commercial cycloheximide (Melford
Laboratories) was subjected tomass spectrometry where it gave an ion
at m/z=304.152 [M+Na]+ (Fig. 7C). Additionally, the fragmentation
pattern of the cycloheximide-derived ion at m/z=304.1519 [M+Na]+
was identical to the fragmentation pattern of the 5307(1B)-derived ion
at m/z=304.1525 [M+Na]+ (Fig. 7B,D) confirming that our initial
identification of the 5307(1B) bioactive compound as cycloheximide
was correct.
To demonstrate that the phenotype exhibited by 5307(1B) and
cycloheximide-treated S. pombe are comparable, cells were treated
with 1 mg/ml cycloheximide (Melford Laboratories) and the
phenotype was compared with that of 5307(1B) extract (1:200).
In both cases, an accumulation of cell wall or septal material at
or close to the cell tip and at the site of septation was observed
(Fig. 6B,C). This phenotype has not been previously reported when
S. pombe cells have been treated with cycloheximide. When a
Fig. 4. T342 activates the DNA damage pathway. (A)Wild-type 972h- cells in
the absence of T342 or (B) 6 h after addition of T342. (C) rad3Δ cells in the
absence of T342 or (D) 6 h after addition of T342. (E) cds1Δ cells in the
absence of T342 or (F) 6 h after addition of T342. (G) chk1Δ cells in the
absence of T342 or (H) 6 h after addition of T342. Cells were stained with DAPI
to show DNA, and the white arrows show cells with a cut phenotype. Both
972 h- and cds1Δ cells elongated in the presence of T342; no cut cells were
observed (n=200 cells). Neither rad3Δ nor chk1Δ cells showed any elongation
(n=200 cells). For chk1Δ, 32% of cells and for rad3Δ 30% of cells showed
abnormal DNA segregation (cut phenotype) (n=110 cells and n=100 cells,
respectively). Scale bars: 10 µm.
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higher concentration of commercial cycloheximide (10 mg ml−1)
was used with wild-type cells, SAK950 cells died and did not
exhibit the cell wall phenotype.
Rounded cell phenotype induced by IS1
The final phenotypewe investigated was the rounded cell phenotype
(Fig. 1G) in the presence of IS1. This rounded category included
phenotypes that varied from round cells to wider cells that were still
rod-shaped. IS1 produced a mixed phenotype of rounded cells and
more rod-shaped cells (Fig. 8C,D). Previous work has shown that
rounded/wide cells can be the result of a number of different cellular
defects. For example, defects in nutrient monitoring, growth zone
size and assembly, actin delocalisation or cell wall defects can all
generate this phenotype (Ribas et al., 1991; Mendoza et al., 2005;
Leonhard and Nurse, 2005; Kelly and Nurse, 2011; Thompson and
Sahai, 2015; Verde et al., 1995; Kume et al., 2013).
The compound produced by IS1, which was responsible for
inducing the rounded cell phenotype, was successfully identified
using the protocol described in the Materials and Methods. A peak
common to the active fractions was identified, and a highly purified
extract of the activity, which possesses a distinctive triple-peak
absorbance pattern (Fig. 8A), was obtained by ‘peak picking’. A
sample of this compound was subjected to mass spectrometry and
revealed the presence of an ion at m/z=693.379 [M+H]+ (Fig. 8B).
Querying of the Dictionary of Natural Products for an accurate mass
of 692.371 did not produce any matches indicating, prima facie, that
the compound represents a novel chemical entity.
To confirm that the activity purified from IS1 was responsible for
the rounded cell phenotype, we carried out a filter paper assay
against SAK950 cells and showed that a novel polyene induced the
rounded cell phenotype (Fig. 8C,D). We identified IS1 as a polyene
on the basis of the triple-peak absorbance pattern in the region of
λ=300–450 nm, which is characteristic of polyenes and is used as a
diagnostic aid to identify polyenes during natural product screening,
see the Discussion for further details.
DISCUSSION
In this study, we have screened 657 actinomyces strains for secretion
of activities that affect the cell shape of fission yeast. From the set of
420 strains that produced bioactivities activities, there were 149
Fig. 5. Electrospraymass spectrometry
data for SN purified from T342 and
commercially available SN. (A) SN
purified from T342 [M+Na]+. (B) MS/MS of
the T342-derived SN ion at m/z=529.135
shown in A. (C) Commercially available
SN [M+Na]+. (D) MS/MS of the
commercially available SN ion at
m/z=529.135 shown in C.
Fig. 6. SAK950 cells treated with 5307(1B) or commercially available cycloheximide. Cells were stained with Calcofluor, a fluorescent stain that binds chitin
and cellulose-like structures in the fungal cell wall and septum. (A) Untreated cells. (B) Cells after 6 h in 5307(1B) at 1:200 dilution of purified extract. Results
are representative of n>100 cells; all cells showed abnormal Calcofluor staining. (C) Cells after 6 h in commercially available 1 mg/ml cycloheximide. Of n=145
cells, 82 cells showed abnormal Calcofluor staining and 63 cells showed no Calcofluor staining. Scale bars: 5 µm.
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strains that we decided to follow up and here we have reported the
identification by visual screening, and the purification and
preliminary analysis, of four of these bioactivities as a proof of
principle for this type of approach.
Leptomycin origin and asymmetric phenotype bioactivity
The leptomycins were initially identified in 1983 (Hamamoto et al.,
1983a,b), and the effect of LMB on S. pombewas studied soon after
their purification (Hamamoto et al., 1985). It was shown to cause
cell elongation, and an inhibitory effect of a high concentration of
LMB (10 µg ml−1) on DNA synthesis was observed, although the
primary effect was suggested to be inhibition of mitotic exit without
blocking septation (Hamamoto et al., 1985). LMB-resistant mutants
in S. pombe resulted in the identification of crm1 as the cellular
target and that LMB binds covalently to Crm1 at a cysteine residue
in a conserved region of the protein (Kudo et al., 1998; Kudo et al.,
1999). Crm1 mediates the export of proteins possessing nuclear
export signals (NES) from the nucleus to the cytoplasm (Kudo et al.,
1998; Fukuda et al., 1997; Stade et al., 1997) and has been
implicated in a number of different cellular processes in different
organisms, including centromere and telomere arrangement
(Funabiki et al., 1993). Crm1 is linked to the spindle pole body
(SPB) by Spc72 (Neuber et al., 2008) and is involved in locating
pericentrin to the centrosome (Liu et al., 2009). In addition, it is
associated with nucleophosmin and is involved in regulating
centrosome duplication (Wang et al., 2005; Shinmura et al.,
2005). It has also been shown that centrin and pericentrin
accumulate in the nucleus following treatment with LMB (Keryer
et al., 2003). LMB competes with the NES for stable formation of a
complex with Ran-GTP. Ran-GTP stabilises microtubule plus-ends
and has been shown to concentrate at the centrosome (Keryer et al.,
2003), and in S. pombe, it interacts with at least one component of
the SPB and controls microtubule integrity (Fleig et al., 2000).
Our results suggest that a significant effect of LMB is on the
microtubule cytoskeleton, and we suggest that this leads directly
to mis-positioning of the nucleus and septum. Although the LMB
phenotype has been well characterised (see above), this is the first
time that a septum-positioning defect has been reported for LMB
in S. pombe. It is tempting to interpret the major LMB-induced
S. pombe cell morphology phenotype in terms of disruption of
Crm1 functions relating to the export of factors affecting the
interphase microtubules, but it is possible that there are other
factors whose Crm1-dependent export/localisation are also
affected. Indeed, it has been shown that the localisation of 285
proteins, many of which are involved in cell cycle, cell division
and cell morphology processes, are dependent on Crm1, and
therefore subject to LMB-mediated disruption (Matsuyama et al.,
2006).
Many tumour suppressors and oncoproteins use Crm1 for their
nuclear export and, as the best-characterised nuclear export
inhibitor, LMB has been a candidate for anti-cancer drug
development, although it failed clinical trials due to toxicity.
Nonetheless, the search for natural products that possess nuclear
export inhibitory activity has continued (Cautain et al., 2014;
Mutka, et al., 2009) and our results show that the S. pombe
morphological effect could provide a means of screening for novel
inhibitors of this class.
SN origin and cell elongation phenotype
SN was first isolated from Streptomyces flocculus (Rao and Cullen,
1960), although identical molecules have also been isolated from
other species; for example, ‘bruneomycin’ from Actinomyces albus
var bruneomycin (Brazhnikova, et al., 1968). The structure of SN has
been elucidated (Rao et al., 1963) and it possesses an aminoquinone
moiety, in commonwithmanyother bioactive agents of actinomycete
origin, including mitomycin C, actinomycin, rifamycin and
geldanamycin. SN has been shown to exert its anti-tumour effects
through direct and indirectly acting mechanisms (reviewed in Bolzán
and Bianchi, 2001). SN acts to damage DNA directly when it forms
complexes with metal ions, including Cu2+ (Sugiura et al., 1984), that
are capable of intercalatingwith DNA (Cone et al., 1976). Also, when
the quinone moiety undergoes autoxidation to semiquinone, in the
presence of NADH, reactive oxygen species (ROS) capable of
cleaving DNA are produced (Lown et al., 1978). However, SN also
Fig. 7. Mass spectrometry data
and fragmentation pattern for
cycloheximide purified from 5307(1B)
and commercial cycloheximide.
(A) 5307(1B) [M+Na]+. (B) MS/MS of the
5307(1B)-derived ion at m/z=304.152
shown in A. (C) Sigma cycloheximide
[M+Na]+. (D) MS/MS of the Sigma
cycloheximide-derived ion at
m/z=304.152 shown in C.
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damages DNA indirectly through inhibition of topoisomerase II
activity by binding to the minor groove and stabilising the
transesterification intermediate of the enzyme, so inhibiting re-
ligation of the DNA strands and generating DNA breaks (Yamashita
et al., 1990; Capranico et al., 1994). It has also been shown through in
vitro experiments that SN inhibits the ATPase activity of S. cerevisiae
Rad54 by generating ROS and so prevents Holliday junction branch
migration (Deakayne et al., 2013). In vivo, SNworks through both the
direct and indirect DNA-damaging mechanisms mentioned above,
depending on its concentration, with the inhibition of topoisomerase
function being the predominant mechanism at lower concentrations
(Legault et al., 1997).
Cycloheximide origin and cell wall defect phenotype
One of the more interesting aspects of the present study is the fact
that in several cases the phenotypes observed during the screen are
not due to a direct effect of the natural product compound on its
cellular target but are due to downstream effects caused by
inhibition of the primary target system. The cell wall defect
phenotype observed to occur in response to 53017(1B) was initially
expected to be due to an activity affecting cell wall biosynthesis,
which led to a build-up of aberrant cell wall material within the
cell and consequently to the observed distortions of cellular
morphology. However, isolation of the active compound indicated
that it was cycloheximide, whose identification was consistent with
the similarity between the 16S rRNA gene sequence of strain 5307
(1B) and that of Streptomyces griseus, which produces
cycloheximide (actidione) (Whiffen et al., 1946; Leach et al.,
1947; Kornfeld and Jones, 1948). Cycloheximide is well known as a
general protein synthesis inhibitor (Kerridge, 1958) and is widely
used as a research tool; therefore, the severe effects on the cell wall
were unexpected. However, both cycloheximide and 5307(1B)
extract induce a similar phenotype, with the S. pombe cell wall
becoming thickened mainly at one of the cell tips. To our
knowledge, this is the first time that an effect of cycloheximide
on S. pombe cell morphology has been reported.
Fig. 8. The purified novel compound
derived from IS1 causes a rounded cell
phenotype. (A) UV and visible
absorbance spectrum of the IS1
compound. (B) Mass spectrometry data
for compound purified from IS1 [M+H]+.
(C) SAK950 control (left panel), SAK950
cells from the plug assay with IS1 (middle
panel), and SAK950 cells from filter disc
assays with ‘peak-picked’ purified
IS1 compound (right panel).
(D) Representative cells of SAK950
control (left panels) and SAK950+peak
picked IS1 from B shown at higher
magnification (right panels).
Scale bars: 10 µm.
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The differential effects of cycloheximide on the synthesis of the
cell wall components mannan and glucan in S. cerevisiae have been
noted previously, with mannan synthesis being inhibited, whereas
glucan synthesis remains unaffected for a considerable time post
cycloheximide treatment (Elorza, et al., 1976; Sentandreu and
Lampen, 1970; Coen et al., 1994). The thickening of the
S. cerevisiae cell wall following cycloheximide treatment has also
been noted, particularly in the septum region at the tip of the bud
(Rodriguez et al., 1979). Although the effect of cycloheximide
treatment on S. pombe division has been investigated and the
presence of thickened cell plates observed in dividing cells
(Polanshek, 1977), the more-severe phenotype observed in this
study has not been reported previously. Cycloheximide inhibition of
protein synthesis in S. pombe may, as in S. cerevisiae, have a
differential effect on mannan and glucan synthases. If so, then lack
of an effect of cycloheximide on glucan synthases for a period of
time after addition is likely to lead to the accumulation of
unincorporated glucan at the septum in dividing cells and at the
new cell tips generated at cell division, producing the aberrant cell
wall S. pombe phenotype that we observed.
Identification of the novel IS1 compound
The novel compound IS1 was identified through its ion at
m/z=693.379 [M+H]+ by a search of the Dictionary of Natural
Products. The determination of the absorbance spectrum of the
molecules (Fig. 8A) indicated that it possesses a triple-peak pattern
that is characteristic of molecules possessing a plurality of
conjugated unsaturated carbon–carbon bonds (Oroshnik et al.,
1955). Antifungal compounds that possess similar triple-peak
absorbance spectra include the polyene macrolides (Oroshnik et al.,
1955; Hamilton-Miller, 1973), and the triple-peak absorbance
spectrum is widely used as a diagnostic tool in natural product
screening to identify polyenes (Lemriss et al., 2003; Ouchdouch,
et al., 2001). Based on the maxima of the absorption spectrum, we
would predict that five or six unsaturated bonds are present
(Hamilton-Miller, 1973) and, as during analysis of the IS1
compound by LC-MS a series of ions differing by 18 mass units
were generated (data not shown), it is likely the IS1 compound
possesses a multiplicity of hydroxyl groups that are lost via water as
the major ion species fragments.
Additionally, the cell phenotype induced by IS1 is similar to but
not identical to the rounded phenotype induced by the polyene
antifungal nystatin (data not shown) and may reflect a similar mode
of action. Sterols are well known to play an important role in
maintaining the integrity of lipid rafts, which are responsible, at least
in part, for the correct localisation of protein complexes necessary
for cell morphology/polarity (Takeda, et al., 2004; Takeda and
Chang, 2005; Wachtler et al., 2003; Codlin et al., 2008; Fischer
et al., 2008). Although we do not attempt a precise explanation of
the cell phenotype in terms of the action of the novel IS1 compound,
or indeed of polyenes in general, we note that the rounded/wide
phenotypes are consistent with reduced control of cell morphology/
polarity which leads to loss of, or a less defined, rod-shaped
phenotype.
The drug-sensitive strain used in this study, SAK950, possesses
an erg5Δmutation (Aoi et al., 2014) and so is deficient is ergosterol
(Iwaki et al., 2008), which is known to be a target molecule of
polyenes (Gray et al., 2012). Interestingly, although it was expected
that SAK950 would therefore show some resistance to polyenes its
sensitivity to nystatin is almost identical to the wild-type strain
972h-, although it is more sensitive than wild-type cells to other
available antifungal agents (data not shown). Therefore, it seems
that polyenes, in addition to targeting ergosterol itself, may also be
able to exert a killing effect by interacting with the ergosterol
precursors present in SAK950.
Conclusions
Recently there has been a call for “more concerted screening
campaigns of actinobacterial metabolites against model
eukaryotes…. These screens should harness more than just live/
dead screening. In other words, we should look for interesting
developmental and behavioural phenotypes using well-developed
model systems” (Ho and Nodwell, 2016). The screen described here
aptly fits the above description; we have successfully screened
strains producing putative anti-fungal natural products, from amajor
collection of actinomycete bacteria, for their ability to induce cell
shape defects in S. pombe, with the aim of identifying chemical
entities capable of exerting effects on the cell cycle/cell
morphology. We were successful in identifying many such
strains, which induced a wide range of aberrant phenotypes on
S. pombe. The phenotypic groups we observed are similar to, but not
completely overlapping with those observed after screening of
the S. pombe genome-wide gene deletion collection (Hayles et al.,
2013). As expected, the complexity of phenotypes we have
identified suggests that bioactive compounds may induce a
different range of phenotypic responses than a single gene
knockout would generate, so demonstrating the richness and
complexity of the biological activities the present study has
identified.
Following on from the initial screen, we identified and purified
four compounds, LMB, SN and cycloheximide produced by
actinomycete bacteria B21P2, T342 and 5307(1B), respectively,
and a novel compound from actinomycete bacterium IS1. These
results demonstrate that this type of screen will identify both known
compounds of biological interest and novel compounds. We have
analysed the S. pombe phenotypes in the presence of these drugs
and found that they correlate with the known or predicted
bioactivities of these compounds. These four case studies confirm
the validity of our approach to identify bioactivities affecting
S. pombe cell cycle and cell morphology, and suggest that some of
the other 149 activities that we are currently investigating will be
novel, biologically important activities affecting these processes in
S. pombe. Given the conservation of genes encoding proteins
involved in the cell cycle and microtubule/actin cytoskeleton
between S. pombe and higher eukaryotes, and the medical use of
some of the compounds affecting the S. pombe cell wall, which may
act as antifungals, it is likely that novel natural products identified in
this way will also be relevant to higher eukaryotes.
MATERIALS AND METHODS
Yeast strains, growth conditions and media
Strains used in this study (Table S2) were grown at 30°C in YE4S (Moreno
et al., 1991) unless otherwise stated.
S. pombemorphological assays
Plug assay
1 ml pipette tips were used to cut agar plugs from lawns of bacterial strains
on GYM agar plates (see below). A plug from each of three different
bacterial strains plus an agar-only control plug was each placed in a quadrant
on a YE4S plate seeded with 5×105 mid-log phase SAK950 cells. Plates
were incubated overnight at 30°C and screened the following day for the
presence or absence of a halo in the S. pombe lawn surrounding the plugs
and microscopically for the phenotype of the S. pombe cells (Fig. 1). This
procedure was carried out after 5, 7 and 9 days of bacterial growth. As
biomolecules diffuse through the agar at different rates and may have
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different effects at different concentrations, the phenotype of the cells was
examined from the plug to the edge of the halo to ensure all phenotypes were
observed (Table S1).
Filter disc assay
Filter discs soaked in extract (10–30 µl with an appropriate amount of H2O
or solvent) (Whatman cat no. 2017-006) instead of bacterial plugs were used
as described above.
DNA damage and checkpoint activation
To assess DNA damage mediated by T342, the T342 extract was added to an
exponentially growing culture of rad52GFP (Lisby et al., 2001) in YE4S liquid
medium and the number of Rad52–GFP foci at 0, 1, 3 and 5 h after addition
were counted and compared to the number upon no T342 extract addition.
To assess checkpoint activation mediated by T342, semi-purified T342
extract (1:100 dilution) was added to 972h-, rad3Δ, cds1Δ and chk1Δ
S. pombe strains growing exponentially in YE4S medium. After 6 h, the cell
phenotype was observed to see whether cells had elongated or had a cut
phenotype (shown by DAPI staining).
Microscopy
Bright-field images of live cells and DAPI-stained cell images were acquired
on a Zeiss Axioskop 40microscopewith a Zeiss 63×/1.4NAoil ph3 objective
and a Zeiss Axiocam MRm camera. For the plug assay plates, cell images
were captured with a Sony HD AVCHD camera using a Zeiss Akioskop 40
microscope with a 50×/0.56 NA Nikon objective and 2.5× Optovar
magnification changer. PN5352 and Rad52–GFP live cells were imaged
using a DeltaVision microscope (Applied Precision) and a 60×/1.42 NA oil
immersion lens. A total of ten z-sections with 0.4 µm spacing were taken with
a Coolsnap-HQ digital CCD camera (Roper Scientific) and deconvolved
using SoftWoRx (Applied Precision). For time-lapse imaging, cells were
grown in YE4S medium at 32°C to early exponential growth, B21P2 was
added and cells were incubated for a further 40 min before transferring to the
microfluidic cell culture system (CellASIC, ONIX). Six z-sections with
0.6 µm spacingwere acquired for each time point with 5min time intervals for
245 min at 32°C using the DeltaVision microscope (Applied Precision). For
the SAK950 cells shown in Fig. 8D, live cells were imaged using a
DeltaVision microscope (Applied Precision) with a 60×/1.42 NA oil
immersion lens after resuspending cells from the edge of colonies in water.
Reagents were used at the following concentrations/dilutions: purified
B21P2 at 1:100 dilution, LMB (Sigma L2913-5UG) at 50 ng/ml, partially
purified T342 at 1:100, purified 5307(1B) at 1:200, xycloheximide (Melford
Laboratories) at 1 mg/ml, Calcofluor (MD Biomedical) at 1:100 dilution of
1:1000 stock in PBS, and DAPI at 1 µg/ml. For filter disc assays, 10 µl
aliquots of 20 µg/ml SN or undiluted T342 were used.
Bacterial strains, growth conditions and media
The Demuris bacterial strain collection comprises over 10,000 actinomyces
strains including a collection of marine-derived actinomycetes collected
byMichael Goodfellow, Newcastle University, UK. The collection is notable
for its diversity with many strains obtained from ecologically unexplored
habitats and/or by novel isolation methodologies, and has been de-replicated
to remove multiple identical strains. 657 strains previously shown to inhibit
the growth of S. cerevisae and/or S. pombe were used in this study. This pre-
screen used semi-purified extracts and/or plug assays for the presence or
absence of a halo but the cell phenotype was not examined. We have
examined all 657 strains over a longer time course for activities having an
effect on cell shape in S. pombe. Strains were resuscitated from storage at
−80°C on oatmeal agar plates (Kieser et al., 2000). For analysis, confluent
bacterial lawns were streaked from the resuscitation plates on Medium H
(GYM) agar plates (Kepplinger, 2016) and grown at 30°C. Growth media
used to optimise production of the bioactivities were mediumA, D (INA5), E
(RA3), F (GPMY), G (V6), H (GYM), I, J, K and V (Kepplinger, 2016). All
media were sterilised at 121°C for 10 min and solid media had agar added
(10 g l−1). Strain B21P2 was isolated from the rhizosphere of Paraserianthes
falcataria (Sembiring, 2000); the most closely related species is
Kitasatospora putterlickiae (16S rRNA gene has 8/1386 bp mismatches).
Strain T342 was first described in Sahin, 1995. The most closely related
species is Streptomyces albus (16S rRNA gene has 14/1438 bp mismatches).
The most closely related species to strain 5307(1B) (ATCC 12433) is
Streptomyces griseus (16S rRNA gene has 0/1379 bp mismatches). The most
closely related species to strain IS1 is Streptomyces misionensis (16S rRNA
gene has 4/1414 bp mismatches).
Production of water- and acetone-based bacterial cell extracts
B21P2 and IS1 were streaked onto GYM agar plates and grown for 7 days.
Production of the bioactivity was assessed by using the plug assay. Agar
from the plates was harvested, disrupted by passaging through a 50 ml
syringe and frozen overnight at −20°C. Awater-based extract was produced
by squeezing the thawed slurry through muslin cheesecloth and filtering the
resultant liquid through Whatman filter paper. A concentrated extract was
obtained by freeze drying the filtered extract in an Edwards ‘Modulyo’
freeze dryer and resuspending the lyophilised material in an appropriate
volume of water. The agar–cell mixture produced was resuspended in a
volume of acetone equal to the initial volume of water-based extract and
incubated overnight at 4°C. Acetone-based extract was produced by
squeezing the mixture through muslin cheesecloth, filtering it and removal
of acetone using a Büchi vacuum rotary evaporator to generate a
concentrated extract comprising the residual water present in the spent
agar–cell slurry.
Production of bioactive crude extracts
B21P2 was streaked onto INA5 agar plates, T342 onto GYM agar plates and
5307(1B) onto Medium A plates. All strains were grown for 7 days and
production of bioactive compounds assessed by use of the plug assay. Agar
from the plates was harvested, disrupted by passaging through a 50 ml
syringe and frozen overnight at −20°C. Awater-based extract was produced
by squeezing the thawed slurry through muslin cheesecloth and filtering the
resultant liquid through Whatman filter paper. Washed Amberlite™
XAD16N resin beads (Sigma) were added (20 g l−1) to the resultant
liquid to adsorb bioactive compounds. The liquid was successively extracted
three times with portions of Amberlite™ resin beads, and the compounds
released by washing the resin with volumes of methanol equal to the volume
of the liquid extract. The methanol was removed by rotary evaporation
(Büchi) to obtain water-based concentrates.
Reverse-phase flash chromatography
The B21P2- and 5307(1B)-derived water-based concentrates, and IS1-
derived acetone-based concentrates were passed through a pre-packed
disposable reverse-phase C18 25 g SNAP flash chromatography column
(Biotage) and the bound compounds eluted in a 0–100%water (0.1% formic
acid)–methanol (0.1% formic acid) gradient using a Biotage Isolera One
chromatography machine. T342-derived extract produced by resuspension
of ‘freebased’material (see ‘Solvent Extraction’ below) in water was treated
similarly. For all strains, fractions containing bioactive compounds were
identified by spotting 30 µl aliquots onto filter paper discs, which were used
in the filter disc assay. Active fractions producing a halo of cells with the
expected characteristic phenotypes were pooled and the methanol removed
by a GeneVac Series II system equipped with a GeneVac VC3000TA
condenser unit.
Thin layer chromatography
B21P2- and 5307(1B)-derived samples were subjected to thin layer
chromatography (TLC) using silica gel plates (Fluka Analytical) and a
range of solvents: ethyl acetate, methanol and diethyl ether. After running
the samples, the TLC plates were pressed, silica side down, onto YE4S agar
plates and the position of the TLC plates, sample loading site and solvent
front were recorded on the back of the petri dish. After a 30 min transfer
period the TLC plates were removed and the YE4S agar plates were
inoculated with S. pombe in a similar fashion to in the plug and filter paper
assays. After an overnight incubation at 30°C, zones of inhibition in the
S. pombe lawns comprising cells of aberrant morphology indicated the
presence of bioactive compounds of interest and comparison of the location
of these zones with the solvent front and sample loading site markings
allowed assessment of the solubility of the bioactive compound in the
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various solvents and selection of the most appropriate solvent(s) for future
purification steps.
Solvent extraction
Ethyl acetate extractions of B21P2- and 5307(1B)-derived material were
obtained by shaking the aqueous extract with an equal volume of ethyl
acetate in a separating funnel for 5 min followed by separation of the two
phases. The ethyl acetate phase was rotary evaporated with silica so as to
adsorb the compounds therein. A ‘freebasing’ process was employed with
regard to T342-derived extracts where the pH of the aqueous extract (pH 8)
was raised to pH 10 and an ethyl acetate extraction used to remove
contaminants in the organic phase. This was followed by alteration of the pH
of the aqueous phase to pH 4 and again obtaining an ethyl acetate extraction
where the bioactive compound migrated into the organic phase, after which
it was recovered by rotary evaporation (Büchi) and resuspended in water.
Normal-phase flash chromatography and size exclusion
chromatography
The silicawith adsorbedB21P2-derived compoundwas transferred into a pre-
packed, disposable K-Sil 25 g SNAP column (Biotage) and used in normal-
phase flash chromatography with elution in a 0–100% diethyl ether–ethyl
acetate gradient. The silica with adsorbed 5307(1B)-derived compound was
similarly treated with elution in a 0–100% dichloromethane–methanol
gradient. For both strains, fractions containing bioactive compounds were
identified by spotting 30-µl aliquots onto filter paper discs which were used,
as described above, to identify active fractions producing a halo comprising
cells exhibiting the expected characteristic phenotypes. For B21P2, active
fractions were pooled, the solvent removed using a GeneVac Series II and the
resultant sample was loaded onto a 150 PSI Max (Omnifit) size exclusion
column packed with Sephadex™ LH-20 connected to a Biotage Isolera One
chromatography machine and eluted in a methanol mobile phase. Active
fractions, identified by the filter paper assay, were pooled and the methanol
removed using a GeneVac Series II.
HPLC and mass spectrometry
The B21P2-derived compound was solubilised by addition of 25%
methanol, and 100 µl aliquots were passed through a Perkin Elmer Series
200 HPLC machine equipped with a Phenomenex 150×4.6 mm Synergy
4 µm reverse-phase column and a Hichrom C18 guard column and eluted
using a 43 min 25%–100% water (0.1% formic acid)–acetonitrile (0.1%
formic acid) gradient, with a flow rate of 1 ml min−1 and monitoring at
λ=254 nm. Fractions (0.5 ml) were collected in a 96-well block, and active
fractions identified by the filter paper assay. Following correlation of peaks
in the UV absorbance trace with the active fractions, the method was
repeated with an Agilent Technologies 1260 Infinity liquid chromatography
machine equipped with an integrated fraction collector so as to ‘peak pick’
and collect column eluate corresponding to the peaks of interest. The
gradient used was 25%–100% water (0.1% formic acid)–acetonitrile (0.1%
formic acid) over 15 min ending with a 5 min 100% acetonitrile column
wash using a flow rate of 1 ml min−1 and monitoring with a DAD array at
λ=210, 254, 273, 280, 300, 350 and 600 nm relative to λ=360 nm. T342-
and 5307(1B)-derived compounds were similarly analysed but were eluted
in a gradient of 15%–100% water (0.1% formic acid)–acetonitrile (0.1%
formic acid). IS1-derived compound was passed through an Agilent
150×4.6 mm Eclipse Plus C18 3.5 µm reverse-phase column and a Hichrom
C18 guard column and eluted using a 30 min 30%–100%water– acetonitrile
gradient, with a flow rate of 1 ml min−1 andmonitoring at λ=350 nmwith an
Agilent Technologies 1260 Infinity liquid chromatography machine
equipped with an integrated fraction collector so as to peak pick and
collect column eluate corresponding to the peak of interest.
After removal of solvent, by using the GeneVac Series II, and addition of
25% methanol to enhance solubility, the samples were analysed by
electrospray mass spectrometry (ESI-MS) using a LTQ-FT (Thermo) mass
spectrometer with a 7T magnet at the Pinnacle Laboratory (University of
Newcastle). Experiments were run with a parent/precursor scan at 100,000
resolution. MS/MS fragmentations were carried out in the ion-trap (LTQ)
stage of the instrument. Commercially available LMB (Sigma), SN (Sigma)
and cycloheximide (Melford Laboratories) were used as comparative
standards for the purified molecules of interest. For HPLC, LMB (6.5 µg/ml)
and SN (20 µg/ml) were made up in 20% methanol, and for mass
spectrometry, LMB (11 µg ml−1) was in 50% methanol whereas SN
(20 µg ml−1) and cycloheximide (10 µg ml−1) were in 20% methanol.
Acknowledgements
We thank Dr J. Gray of the ICaMB Pinnacle Laboratory for mass spectrometry and
assistance with the data analysis. We also thank our colleagues at Demuris and in
the Cell cycle lab for stimulating discussions and advice, particularly Scott Curran
and Helena Cantwell.
Competing interests
N.E.E.A. and J.E. hold shares, or share options, in Demuris Ltd.
Author contributions
Conceptualization: R.A.L., J.H., P.M.N.; Methodology: R.A.L.; Formal analysis:
R.A.L., J.L., J.H.; Resources: N.E.E.A., J.E., P.M.N.; Writing - original draft: R.A.L.,
J.H.; Writing - review & editing: R.A.L., J.H., P.M.N.; Supervision: N.E.E.A., J.H.,
P.M.N.; Project administration: J.E.; Funding acquisition: P.M.N.
Funding
This work was supported by the Francis Crick Institute which receives its core
funding from Cancer Research UK (FC001121), the UK Medical Research Council
(FC001121), and the Wellcome Trust (FC001121). In addition this work was
supported by a Wellcome Trust grant to P.N. (grant number 093917) and Demuris.
Deposited in PMC for immediate release.
Supplementary information
Supplementary information available online at
http://jcs.biologists.org/lookup/doi/10.1242/jcs.194571.supplemental
References
al-Khodairy, F., Fotou, E., Sheldrick, K. S., Griffiths, D. J., Lehmann, A. R.
and Carr, A. M. (1994). Identification and characterization of new elements
involved in checkpoint and feedback controls in fission yeast. Mol. Biol. Cell 5,
147-160.
Aoi, Y., Sato, M., Sutani, T., Shirahige, K., Kapoor, T. M. and Kawashima, S. A.
(2014). Dissecting the first and secondmeiotic divisions using amarker-less drug-
hypersensitive fission yeast. Cell Cycle 13, 1327-1334.
Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C. and Spalla,
C. (1969). Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from
S. peucetius var. caesius. Biotechnol. Bioeng. 11, 1101-1110.
Beauchamp, E. M. and Platanias, L. C. (2013). The evolution of the TOR pathway
and its role in cancer. Oncogene 32, 3923-3932.
Bolzán, A. D. and Bianchi, M. S. (2001). Genotoxicity of Streptonigrin: a review.
Mutat. Res. 488, 25-37.
Bonatti, S., Simili, M. and Abbondandola, A. (1972). Isolation of temperature
sensitive mutants of Schizosaccharomyces pombe. J. Bact. 109, 484-491.
Brazhnikova, M. G., Ponomarenko, V. I., Kovsharova, I. N., Kruglyak, E. B. and
Proshlyakova, V. V. (1968). Study on bruneomycin produced by Act. Albus var.
bruneomycini and its identification with Streptonigrin. Antibiotiki 13, 99-102.
Broustas, C. G. and Lieberman, H. B. (2014). DNA damage response genes and
the development of cancer metastasis. Radiat. Res. 181, 111-130.
Capranico, G., Palumbo, M., Tinelli, S. and Zunio, F. (1994). Unique sequence
specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode
of Streptonigrin. J. Biol. Chem. 269, 25004-25009.
Castagnetti, S., Oliferenko, S. and Nurse, P. (2010). Fission yeast cells undergo
nuclear division in the absence of spindle microtubules. PLoS Biol. 8, e1000512.
Cautain, B., de Pedro, N., Garzon, V. M., de Escalona, M. M., Menedez, V. G.,
Tormo, J. R., Martin, J., El Aoud, N., Reyes, F., Asensio, F. et al. (2014). High-
content screening of natural products reveals novel nuclear export inhibitors.
J. Biomol. Screen 91, 57-65.
Chang, F. and Nurse, P. (1996). How fission yeast fission in the middle. Cell 84,
191-194.
Codlin, S., Haines, R. L. and Mole, S. E. (2008). btn1 affects endocytosis,
polarization of sterol-rich membrane domains and polarized growth in
Schizosaccharomyces pombe. Traffic 9, 936-950.
Coen, M. L., Lerner, C. G., Capobianco, J. O. and Goldman, R. C. (1994).
Synthesis of yeast cell wall glucan and evidence for glucan metabolism in a
Saccharomyces cerevisiae whole cell system. Microbiology 140, 2229-2237.
Cone, R., Hasan, S. K., Lown, J. W. and Morgan, A. R. (1976). The mechanism of
degradation of DNA by Streptonigrin. Can. J. Biochem. 54, 219-223.
Daga, R. R., Yonetani, A. and Chang, F. (2006). Asymmetric microtubule pushing
forces in nuclear centering. Curr. Biol. 16, 1544-1550.
Deakayne, J. S., Huang, F., Negri, J., Tolliday, N., Cocklin, S. and Mazin, A. V.
(2013). Analysis of the activities of RAD54, a SWI2/SNF protein, using a specific
small-molecule inhibitor. J. Biol. Chem. 288, 31567-31580.
3183
TOOLS AND RESOURCES Journal of Cell Science (2017) 130, 3173-3185 doi:10.1242/jcs.194571
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Dekanty, A., Barrio, L. andMilán, M. (2015). Contributions of DNA repair, cell cycle
checkpoints and cell death to suppressing the DNA damage-induced tumorigenic
behavior of Drosophila epithelial cells. Oncogene 34, 978-985.
Deshpande, G. F., Hayles, J., Hoe, K. L., Kim, D. U., Park, H. O. and Hartsuiker,
E. (2009). Screening a genome-wide S. pombe deletion library identifies novel
genes and pathways involved in genome stability maintenance. DNA Repair
(Amst) 8, 672-679.
Elorza, M. V., Lostau, C. M., Villanueva, J. R. and Sentandreu, R. (1976). Cell wall
synthesis regulation in Saccharomyces cerevisiae. Effect on RNA and protein
inhibition. Biochimica et Biophysica Acta. 454, 263-272.
Enoch, T., Carr, A. M. and Nurse, P. (1992). Fission yeast genes involved in
coupling mitosis to completion of DNA replication. Genes Dev. 6, 2035-2046.
Fischer, R., Zekert, N. and Takeshita, N. (2008). Polarized growth in fungi -
interplay between the cytoskeleton, positional markers and membrane domains.
Mol. Microbiol. 68, 813-826.
Fleig, U., Salus, S., Karig, I. and Sazer, S. (2000). The fission yeast ran GTPase is
required for microtubule integrity. J. Cell. Biol. 151, 1101-1111.
Fukuda, M., Saano, S., Nakamura, T., Adachi, M., Yoshida, M., Yanagida, M. and
Nishida, E. (1997). CRM1 is responsible for intracellular transport mediated by
the nuclear export signal. Nature 390, 308-311.
Funabiki, H., Hagan, I., Uzawa, S. and Yanagida, M. (1993). Cell cycle-dependent
specific positioning and clustering of centromeres and telomeres in fission yeast.
J. Cell. Biol. 121, 961-976.
Gatti, L., Hoe, K. L., Hayles, J., Righetti, S. C., Carenini, N., Bo, L. D., Kim, D. U.,
Park, H. O. and Perego, P. (2011). Ubiquitin- proteosome genes as targets for
modulation of cisplatin sensitivity in fission yeast. BMC Genomics 12, 44.
Gould, K. L. and Nurse, P. (1989). Tyrosine phosphorylation of the fission yeast
cdc2+ protein kinase regulates entry into mitosis. Nature 342, 39-45.
Graml, V., Studera, X., Lawson, J. L. D., Chessel, A., Geymonat, M., Bortfeld-
Miller, M., Walter, T., Wagstaff, L., Piddini, E. andCarazo-Salas, R. E. (2014). A
genomic Multiprocess survey of machineries that control and link cell shape,
microtubule organization and cell-cycle progression. Dev. Cell 31, 227-239.
Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C. and
Burke, M. D. (2012). Amphotericin primarily kills yeast by simply binding
ergosterol. Proc. Natl. Acad. Sci. USA 109, 2234-2239.
Hamamoto, T., Gunji, S., Tsuji, H. and Beppu, T. (1983a). Leptomycins A and B,
new antifungal antibiotics I taxonomy of the producing strain and their
fermentation, purification and characteristics. J. Antibiot. 36, 639-645.
Hamamoto, T., Seto, H. and Beppu, T. (1983b). Leptomycins A and &, new
antifungal antibiotics II structure elucidation. J. Antibiot. 36, 646-650.
Hamamoto, T., Uozumi, T. and Beppu, T. (1985). Leptomycins A and &, new
antifungal antibiotics III mode of action of leptomycin B on Schizosaccharomyces
pombe. J. Antibiot. 38, 1573-1580.
Hamilton-Miller, J. M. T. (1973). Chemistry and biology of the polyene macrolide
antibiotics. Bacteriol. Rev. 37, 166-196.
Hayles, J., Wood, V., Jeffery, L., How, K.-L., Kim, D.-U., Park, H.-O., Salas-Pino,
S., Heichinger, C. and Nurse, P. (2013). A genome wide resource of cell cycle
and cell shape genes of fission yeast. Open Biol. 3, 130053.
Heisler, J., Elvir, L., Barnouti, F., Charles, E., Wolkow, T. D. and Pyati, R. (2014).
Morphological effects of natural products on Schizosaccharomyces pombe
measured by imaging flow cytometry. Nat. Prod. Bioprospect. 4, 27-35.
Ho, L. K. and Nodwell, J. R. (2016). David and Goliath: chemical perturbation of
eukaryotes by bacteria. J. Ind. Microbiol. Biotechnol. 43, 233-248.
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamura, T., Brem, H. and
Folkman, J. (1990). Synthetic analogues of Fumagillin that inhibit angiogenesis
and suppress tumour growth. Nature 348, 555-557.
Iwaki, T., Iefuji, H., Hiraga, Y., Hosomi, A., Morita, T., Giga-Hama, Y. and
Takegawa, K. (2008). Multiple functions of ergosterol in the fission yeast
Schizosaccharomyces pombe. Microbiology 154, 830-841.
Johnson, R. and Halder, G. (2014). The two faces of Hippo: targeting the Hippo
pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov.
13, 63-79.
Kawashima, S. A., Chen, Z., Aoi, Y., Patgiri, A., Kobayashi, Y., Nurse, P. and
Kapoor, T. M. (2016). Potent, reversible, and specific chemical inhibitors of
eukaryotic ribosome biogenesis. Cell 167, 512-524.
Kelly, F. D. andNurse, P. (2011). Spatial control of Cdc42 activation determines cell
width in fission yeast. Mol. Biol. Cell. 22, 3801-3811.
Kelly, T. J., Martin, G. S., Forsburg, S. L., Stephen, R. J., Russo, A. andNurse, P.
(1993). The fission yeast cdc18+ gene product couples S phase to START and
mitosis. Cell 74, 371-382.
Kepplinger, B. (2016). The discovery and characterisation of antibiotics from
Amycolatopsis isolate DEM30355. EngD thesis, University of Newcastle,
Newcastle-upon Tyne, UK.
Kerridge, D. (1958). The effect of actidione and other antifungal agents on nucleic
acid and protein synthesis in Saccharomyces carlsbergensis. J. Gen. Microbiol.
19, 497-506.
Keryer, G., DiFiore, B., Celati, C., Lechtreck, K. F., Mogensen, M., Delouvée, A.,
Lavia, P., Bornens, M. and Tassin, A.-M. (2003). Part of Ran is associated with
AKAP450 at the centrosome: involvement inmicrotubule –organising activity.Mol.
Biol. Cell. 14, 4260-4271.
Kieser, T., Bibb, M. J., Buttner, M. J., Chater, K. F. and Hopwood, D. A. (2000).
Practical Streptomyces Genetics. Norwich: The John Innes Foundation.
Kornfeld, E. C. and Jones, R. G. (1948). The structure of actidione, and antibiotic
from Streptomyces griseus. Science 108, 437-438.
Kudo, N., Wolff, B., Sekimoto, T., Schreiner, E. P., Yoneda, Y., Yanagida, M.,
Hornouchi, S. and Yoshida, M. (1998). Leptomycin B inhibition of signal
mediated nuclear export by direct binding to Crm1. Exp. Cell. Res. 242, 540-547.
Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schrreiner, E. P., Wolff, B.,
Yoshida, M. and Horinouch, S. (1999). Leptomycin B inactivates CRM1/exportin
by covalent modification at a cysteine residue in the central conserved region.
Proc. Natl. Acad. Sci. USA 96, 9112-9117.
Kume, K., Kubota, S., Koyano, T., Kanai, M., Mizunuma, M., Toda, T. and Hirata,
D. (2013). Fission yeast leucine-rich repeat protein Lrp1 is essential for cell
morphogenesis as a component of the morphogenesis Orb6 network (MOR).
Biosci. Biotechnol. Biochem. 77, 1086-1091.
Leach, B. E., Ford, J. H. and Whiffen, A. J. (1947). Actidione, an antibiotic from
Streptomyces griseus. J. Am. Chem. Soc. 69, 474.
Legault, J., Tremblay, A., Ramotar, D. and Mirault, M.-E. (1997). Clusters of S1
nuclease-hypersensitive sites induced in vivo by DNA damage.Mol. Cell. Biol. 17,
5437-5452.
Lemriss, S., Laurent, F., Couble, A., Casoli, E., Lancelin, J. M., Saintpierre-
Bonaccio, D., Rifai, S., Fassouane, A. and Boiron, P. (2003). Screening of
nonpolyenic antifungal metabolites produced by clinical isolates of
actinomycetes. Can. J. Microbiol. 49, 669-674.
Leonhard, K. and Nurse, P. (2005). Ste20/GCK kinase Nak1/Orb3 polarizes the
actin cytoskeleton in fission yeast during the cell cycle. J. Cell. Sci. 118,
1033-1044.
Lisby, M., Rothstein, R. and Mortensen, U. H. (2001). Rad52 forms DNA repair
and recombination centers during S phase. Proc. Natl. Acad. Sci. USA 98,
8276-8282.
Liu, Q., Jiang, Q. and Zhang, C. (2009). A fraction of Crm1 locates at centrosomes
by its CRIME domain and regulates the centrosomal location of pericentrin.
Biochem. Biophys. Res. Commun. 384, 383-388.
Lown, J.W., Sim, S.-K. and Chen, H.-H. (1978). Hydroxyl radical production by free
and bound aminoquinone antibiotics. Can. J. Biochem. 56, 1042-1047.
Matsuyama, A., Arai, R., Yashiroda, Y., Shirai, A., Kamata, A., Sekido, S.,
Kobayashi, Y., Hashimoto, A., Hamamoto, M., Hiraoka, Y. et al. (2006).
ORFeome cloning and global analysis of protein localization in the fission yeast
Schizosaccharomyces pombe. Nat. Biotechnol. 27, 841-847.
Mendoza, M., Redemann, S. and Brunner, D. (2005). The fission yeast MO25
protein functions in polar growth and cell separation. Eur. J. Cell. Biol. 84,
915-926.
Moreno, S., Klar, A. and Nurse, P. (1991). Molecular genetic analysis of fission
yeast schizosaccharomyces pombe. Methods Enzymol. 194, 795-823.
Mitchison, J. M. and Nurse, P. (1985). Growth in cell length in the fission yeast
Schizosaccharomyces pombe. J. Cell Sci. 75, 357-376.
Mutka, S. C., Yang, W. Q., Dong, S. D., Ward, S. L., Craig, D. A., Timmermans,
P. B. andMurli, S. (2009). Identification of the nuclear export inhibitors with potent
anticancer activity in vivo. Cancer Res. 69, 510-517.
Nasmyth, K. and Nurse, P. (1981). Cell division cycle mutants altered in DNA
replication and mitosis in the fission yeast Schizosaccharomyces pombe. Mol.
Gen. Genet. 182, 119-124.
Navarro, F. J. and Nurse, P. (2012). A systematic screen reveals new elements
acting at the G2/M cell cycle control. Genome Biol. 13, R36.
Neuber, A., Franke, J., Wittstruck, A., Schlenstedt, G., Sommer, T. and Stade,
K. (2008). Nuclear export receptor Xpo1/Crm1 is physically and functionally linked
to the spindle pole body in budding yeast. Mol. Cell Biol. 28, 5348-5358.
Nishi, K., Yoshida, M., Fujiwara, D., Nishiikawa, M., Horinouchi, S. and Beppu,
T. (1994). Leptomycin B targets a regulatory cascade of crm1, a fission yeast
nuclear protein, involved in control of higher order chromosome structure and
gene expression. J. Biol. Chem. 269, 6320-6324.
Nurse, P. (1990). Universal control mechanism regulating onset of M-phase.Nature
344, 503-508.
Nurse, P. and Thuriaux, P. (1980). Regulatory genes controlling mitosis in the
fission yeast Schizosaccharomyces pombe. Genetics 96, 627-637.
Nurse, P., Thuriaux, P. and Nasmyth, K. (1976). Genetic control of the cell division
in the fission yeast Schizosaccharomyces pombe. Mol. Gen. Genet. 146,
167-178.
Oroshnik, W., Vining, L. C., Mebane, A. D. and Taber, W. A. (1955). Polyene
antibiotics. Science 121, 147-149.
Ouchdouch, Y., Barakate, M. and Finance, C. (2001). Actinomycetes of Moroccan
habitats: isolation and screening for antifungal activities. Eur. J. Soil Biol. 37,
69-74.
Paoletti, A. and Chang, F. (2000). Analysis of mid1p, a protein required for
placement of the cell division site, reveals a link between the nucleus and the cell
surface in fission yeast. Mol. Biol. Cell. 11, 2757-2773.
Polanshek, M. M. (1977). Effects of heat shock and cycloheximide on growth and
division of the fission yeast Schizosaccharomyces pombe. J. Cell. Sci. 23, 1-23.
Rao, K. V. andCullen,W. P. (1960). Streptonigrin, an antitumor substance.Antibiot.
Annu. 1959-1960, 950-953.
3184
TOOLS AND RESOURCES Journal of Cell Science (2017) 130, 3173-3185 doi:10.1242/jcs.194571
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Rao, K. V., Biemann, K. and Woodward, R. B. (1963). The structure of
Streptonigrin. J. Am. Chem. Soc. 85, 2532-2533.
Ribas, J. C., Diaz, M., Duran, A. and Perez, P. (1991). Isolation and
characterization of Schizosaccharomyces pombe mutants defective in cell wall
(1-3) beta-D-glucan. J. Bacteriol. 173, 3456-3462.
Rodriguez, L., Laborda, F. and Sentandreu, R. (1979). Patterns of wall synthesis
in Saccharomyces cerevisiae. Curr. Microbiol. 2, 293-297.
Russell, P. and Nurse, P. (1986). Cdc25+ functions as an inducer in the mitotic
control of fission yeast. Cell 45, 145-153.
Russell, P. and Nurse, P. (1987). Negative regulation of mitosis by wee1+, a gene
encoding a protein kinase homolog. Cell 49, 559-567.
Sahin, N. (1995). Selective isolation and classification of novel thermotolerant
Streptomycetes. PhD thesis, University of Newcastle, Newcastle upon Tyne, UK.
Saka, Y. and Yanagida, M. (1993). Fission yeast cut5+, required for S phase onset
and M phase restraint, is identical to the radiation-damage repair gene rad4+. Cell
74, 383-393.
Sato, M. and Toda, T. (2010). Space shuttling in the cell: nucleocytoplasmic
transport and microtubule organization during the cell cycle. Nucleus 1, 231-236.
Sembiring, L. (2000). Selective isolation and characterization of Streptomycetes
associated with the rhizosphere of the tropical legume Paraserianthes falcataria
(L) Nielsen. PhD thesis, University of Newcastle, Newcastle upon Tyne, UK.
Sentandreu, R. and Lampen, J. O. (1970). Biosynthesis of yeast mannan: inhibition
of synthesis of mannose acceptor by cycloheximide. FEBS Lett. 11, 95-99.
Shinmura, K., Tarapore, P., Tokuyama, Y., George, K. R. and Fukasawa, K.
(2005). Characterisation of centrosomal association-of nucleophosmin/B23
clinked to Crm1 activity. FEBS Lett. 579, 6621-6634.
Simanis, V. and Nurse, P. (1986). The cell cycle control gene cdc2+ of fission yeast
encodes a protein kinase potentially regulated by phosphorylation.Cell 45, 261-268.
Snaith, H. A. and Sawin, K. E. (2003). Fission yeast mod5p regulates polarised
growth through anchoring of tea1p at cell tips. Nature 423, 647-651.
Stade, K., Ford, C. S., Guthrie, C. and Weis, K. (1997). Exportin 1 (Crm1p) is an
essential nuclear export factor. Cell 90, 1041-1050.
Sugiura, Y., Kuwahara, J. and Suzuki, T. (1984). DNA interaction and nucleotide
sequence cleavage of copper-streptonigrin. Biochem. Biophys. Acta. 782,
254-261.
Takeda, T. and Chang, F. (2005). Role of fission yeast myosin 1 in organisation of
sterol-rich membrane domains. Curr. Biol. 15, 1331-1336.
Takeda, T. Kawate, T. and Chang, F. (2004). Organization of a sterol-rich
membrane domain by cdc15p during cytokinesis in fission yeast.Nat. Cell. Biol. 6,
1142-1144.
Takemoto, A., Kawashima, S. A., Li, J. J., Jeffery, L., Yamatsugu, K., Elemento,
O. and Nurse, P. (2016). Nuclear envelope expansion is crucial for proper
chromosomal segregation during a closed mitosis. J. Cell Sci. 129, 1250-1259.
Tange, Y., Hirata, A. and Niwa, O. (2002). An evolutionarily conserved fission yeast
protein, Ned1, implicated in normal nuclear morphology and chromosome
stability, interacts with Dis3, Pim1/RCC1 and an essential nucleoporin. J. Cell
Sci. 115, 4375-4385.
Thompson, B. J. and Sahai, E. (2015). MST kinases in development and disease.
J. Cell Biol. 131, 1529-1538.
Tsuchiya, E., Yukawa, M., Ueno, M., Kimura, K. and Takahashi, H. (2010). A
novel method of screening cell-cycle blockers as candidates for anti-tumor
reagents using yeast as a screening tool. Biosci. Biotechnol. Biochem. 74,
411-414.
Umenzawa, H., Maeda, K., Takeuchi, T. and Okami, Y. (1966). New antibiotics,
bleomycin A and B. J. Antibiot. 19, 200-209.
Verde, F., Mata, J. and Nurse, P. (1995). Fission yeast cell morphogenesis:
identification of new genes and analysis of their role during the cell cycle. J. Cell
Biol. 131, 1529-1538.
Wachtler, V., Rajagopalan, S. and Balasubramanian, M. K. (2003). Sterol-rich
plasma membrane domains in the fission yeast Schizosaccharomyces pombe.
J. Cell. Sci. 116, 867-874.
Wang, W., Budhu, A., Forgues, M. and Wang, X. W. (2005). Temporal and spatial
control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.
Nat. Cell. Biol. 7, 823-830.
Whiffen, A. J., Bohonos, N. and Emerson, R. L. (1946). The production of an
antifungal antibiotic by Streptomyces griseus. J. Bacteriol. 52, 610-611.
Wood, V., Gwilliam, R., Rajandream, M.-A., Lyne, M., Lyne, R., Stewart, A.,
Sgouros, J., Peat, N., Hayles, J., Baker, S. et al., (2002). The genome sequence
of Schizosaccharomyces pombe. Nature 415, 871-880.
Yamashita, Y., Kawada, S.-Z., Fujii, N. and Nakano, H. (1990). Induction of
mammalian DNA topoisomerase II dependent DNA cleavage by antitumor
antibiotic Streptonigrin. Cancer Res. 50, 5841-5844.
Yanagida, M. (1998). Fission yeast cut mutations revisited: control of anaphase.
Trends Cell Biol. 8, 144-149.
3185
TOOLS AND RESOURCES Journal of Cell Science (2017) 130, 3173-3185 doi:10.1242/jcs.194571
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
